Notice Number: NOT-HL-09-125
Key Dates
Release Date: April 2, 2009
Issued by
National Heart, Lung, and Blood Institute (NHLBI), (http://www.nhlbi.nih.gov)
Purpose
On February 23, 2009, the NHLBI issued a Funding Opportunity Announcements (FOA): RFA-HL-10-003 (Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01) http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-10-003.html.
As a result of discussions with potential applicants, a list of Frequently Asked Questions (FAQs) has been developed.
The FAQs for this FOA can be found at: http://www.nhlbi.nih.gov/funding/inits/faq-phase2.htm. This information may be updated periodically without additional notice. NHLBI staff will also respond to questions submitted by potential applicants who contact the program, grants management, and review staff listed in the FOA in the Agency Contacts section.
All other aspects of this FOA remain unchanged.
Inquiries
Inquiries should be directed to:
Andrea L. Harabin, Ph.D.
Division of Lung Diseases
National Heart, Lung, and Blood Institute
6701 Rockledge Drive
Bethesda, MD 20892-7952
Telephone: (301) 435-0222
Email: harabina@nhlbi.nih.gov
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files. |